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Abstract
Genetic variation is known to influence the amount of mRNA produced by a
gene. Given that the molecular machines control mRNA levels of multiple genes,
we expect genetic variation in the components of these machines would influence
multiple genes in a similar fashion. In this study we show that this assumption is
correct by using correlation of mRNA levels measured independently in the brain,
kidney or liver of multiple, genetically typed, mice strains to detect shared genetic
influences. These correlating groups of genes (CGG) have collective properties that
account for 40–90% of the variability of their constituent genes and in some cases,
but not all, contain genes encoding functionally related proteins. Critically, we show
that the genetic influences are essentially tissue specific and consequently the same
genetic variations in the one animal may up–regulate a CGG in one tissue but down–
regulate the same CGG in a second tissue. We further show similarly paradoxical
behaviour of CGGs within the same tissues of different individuals. The implication
of this study is that this class of genetic variation can result in complex inter– and
intra–individual and tissue differences and that this will create substantial challenges
to the investigation of phenotypic outcomes, particularly in humans where multiple
tissues are not readily available.
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Introduction
Gene expression is controlled by multiple molecular machines whose interaction with
a gene and genes transcript contributes to determining a final level of mRNA; recent
studies have shown that these processes are subject to significant influences of genetic
variation that result in heritable changes to final mRNA levels (reviewed by Cotsapas
et al., 2006; Gibson and Weir, 2005; Rockman and Kruglyak, 2006; Williams et al., 2007).
In multicellular organisms, these molecular machines are involved in setting mRNA lev-
els of many genes but they contain different components; some may be common to the
expression of all genes in all cells of the organism whereas other components may have
more limited function such that that are involved with sub sets of genes or sub sets
of cell types, or both (Maniatis and Reed, 2002; Tsankov et al., 2006; Maciag et al.,
2006; Komili and Silver, 2008). We therefore predict that genetic perturbation of these
machines will result in either global or cell–type specific changes to gene expression,
depending on the variant component. Such behaviour is in marked contrast to genetic
variation in protein coding sequence, where the variant is observed in all cases where
the gene is expressed. In this work, we use correlation based methods to show that
the effects of regulatory variation are, as predicted, coordinated changes to the mRNA
levels of groups of genes. These group changes can be very different both in multiple
tissues of the same individual, as well as being different in the same tissues of multiple
individuals. We use the term regulatory variation to describe any genetic variation that
affects the amount of mRNA produced from a gene; it can occur through the disrup-
tion of cis–regulatory sequences, such as promoter or enhancer elements, or through
changes to trans–acting components, including any of the molecular machinery that
controls the amount of steady state mRNA in a cell, such as transcription or splicing
factors (Williams et al., 2007). The majority of findings to date, using predominantly
expression QTL (eQTL) experimental designs, suggest that cis–acting regulatory varia-
tion appears to be of larger effect size, and is thus more easily detected; in comparison,
trans–regulatory variation appears to be of smaller effect size, and are either less com-
mon, or harder to detect (Petretto et al., 2006; Stranger et al., 2005; Goring et al., 2007).
When trans–acting influences are identified, these tend to be a small number of eQTLs
that influence the expression of large numbers of genes, so called “master–regulator” of
gene expression, suggesting that regulatory variation is affecting the expression level of
groups of genes, simultaneously. Investigating trans–acting regulatory variation using
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eQTL analysis is presently beset both by very substantial statistical problems of multiple
hypothesis testing and by the sheer scale of studies required to provide genetic power
to detect small effect sizes. Further, whilst eQTL analysis is an appropriate approach
to investigate the effects caused by one or a small number of genetic influences, it has
limited power to detect additional eQTLs with smaller effect sizes (Brem and Kruglyak,
2005; Williams et al., 2007). To overcome this limitation, several groups have used
correlation–based approaches to identify groups of genes that covary under the influ-
ence of simple or complex genetic influences (Ghazalpour et al., 2006; Lan et al., 2006).
The conceptual basis of such experiments is simple: mRNA levels that vary similarly
across multiple individuals are likely to do so because of shared sensitivity to genetic
influences. Correlation–based approaches have the added advantage that we are mea-
suring the shared outcome of regulatory variation stemming from multiple genetic loci,
the modest contributions of which eQTL analysis would be underpowered to detect in
all but the largest studies.
In this study of inbred and recombinant inbred mice, we set out to investigate trans–
acting regulatory variation, using correlation analysis to identify groups of genes that
are likely to be influenced by shared regulatory variation, and thus shared regulatory
factors. We further investigate the consequence of trans–acting regulatory variation in
three different mouse tissues to assess the degree to which (A) genes are affected by the
same regulatory variation in all tissues, and (B) whether the outcome of such regulatory
variation is the same in all tissues.
Overview of experimental design
To identify genes whose expression levels may be affected by regulatory variation, and
to investigate their regulation in multiple tissues, we adopt the following experimental
design: first, we compare gene expression levels in 3 tissues of two inbred mouse strains,
C57BL/6J and DBA/2J, and 31 strains of the BXD recombinant inbred (RI) panel
derived from these two progenitors. Next, we look for genes whose expression differs
between the progenitor strains in at least one of these tissues; within these we identify
subsets of genes whose mRNA levels vary co–ordinately across the BXD RI strains and
the three tissues; we term these “correlating groups of genes” or CGGs. We validate the
shared regulatory influences acting upon these CGGs by testing the conservation of their
expression changes in both the parental strains and in the distantly related inbred strain
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SJL/J. We further investigate the specific outcomes of the regulation of these CGGs in
the three tissues of the BXD panel.
Identify genetically influenced genes
We began by identifying genes differentially expressed in at least one of whole brain,
kidney, or liver between strains C57BL/6J and DBA/2J. We found that we could reliably
detect 6075 transcripts above background in all three tissues, of which 755 were variantly
expressed between the two strains at a LOD>3 (the B–statistic of Lonnstedt and Speed
(2002), as modified by Smyth (2004); see Methods). We ascribe this consistent variation
in gene expression to regulatory variation, since environmental factors have been reduced
to a minimum. We stress that we have deliberately avoided selecting genes that are
expressed in a “tissue specific” manner, in the sense of being expressed in only 1 or 2 of
the 3 tissues (Supplementary Figure 1).
The identification of 755 genes as being potential targets of regulatory variation(s)
does not us allow us to identify if each gene is under a unique or shared influence. To
do this, we need to study the 755 genes in multiple, changing, genetic backgrounds
reasoning that we could then detect shared influence by detecting highly correlated
alterations mRNA levels of otherwise unrelated genes. Such correlated changes could in
principle be observed between genes within either single or multiple tissues. We chose
to search for mRNA correlations across multiple tissues in the first instance and then
further studied the behaviour in the individual tissues seeking to ask if the outcome of
genetic influence on genes is the same in each tissue.
Identifying groups of genes with similar expression patterns
in multiple tissues
To achieve this, we measured mRNA levels of the 755 genes in the same 3 tissues in 31
BXD recombinant inbred (RI) strains (Taylor et al., 1999), pooling three age– and sex–
matched mice from each. These strains have been derived from crosses of C57BL/6J and
DBA/2J, which have been bred to homozygosity by repeated sibling pair mating. As
they carry arbitrary mixtures of the two progenitor backgrounds, but are homozygous
at each locus, we predict that most strains will have inherited some of the C57BL/6J
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alleles and some of the DBA/2J alleles, of any factors, basal or conditional, controlling
the mRNA levels of the 755 genes. If these factors influence more than a single transcript,
we would predict that the levels of these co–influenced mRNAs would correlate across
the BXD panel, thus forming a CGG.
In order to identify those genes that have similar expression patterns in all 31 BXD
strains and in all 3 tissues, we adopted a correlation–network approach (see Methods).
We compare all pairwise combinations of 755 gene expression patterns across the 93
measurements, and construct correlation networks consisting of nodes representing genes,
and edges representing correlations that are stronger than an empirically determined
threshold.
The correlation–network approach has a number of advantages: the resulting net-
works summarise a large amount of complex data in a form that is easily visualised and
interpreted, and there are a number of techniques for identifying discrete regions of the
network corresponding to CGGs. Most importantly, the number of groups does not need
to be known a priori as in clustering methods, and those genes that are not correlated
highly enough are automatically filtered from the resulting network, thus reducing the
noise in the system.
Choice of threshold for network construction and network
properties
To display the complex relationship between genes and multiple pairwise correlations
we construct networks using the widely used approach of thresholding correlation ma-
trices (Freeman et al., 2007; Voy et al., 2006). The intention of thresholding is to define
discrete groups of genes that can be subject to other analyses but we stress that there
is no plausible reason why a threshold should have an explicit biological meaning, as
regulation–induced correlation can be of any magnitude. An important step in con-
structing such networks is choice of threshold: too low a threshold will result in a too
densely connected graph, while too high a threshold will result in a sparsely populated
and connected network (Freeman et al., 2007). The final choice of threshold is guided
entirely by the overall objectives of the analysis. Our primary aim is to identify groups of
co–regulated genes that are plausibly under common genetic control, so we focus on find-
ing groups of interconnected genes that are distinct from other such groups (connected
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components in graph theoretical terms, unconnected to others).
We focused on identifying a correlation threshold that would (A) provide an adequate
number of connected components that had at least 2 genes; (B) distinguish the graph–
theoretic properties of the 755 genes from those of all expressed genes. To do so, we
studied various network properties of these genes, treating them as test–statistics, and
examined how unusual these properties were using 1000 sets of the same size randomly
sampled from the 6075 genes that were expressed in all three tissues. We studied 6 graph–
theoretic properties in this fashion (Figure 1), namely: (1) the number of correlations
above the threshold; (2) the number of connected components; (3) the median of the
distribution of connected component size; (4) size of the largest connected component,
(5) average degree, computed across non–singleton connected components and (6) the
global clustering coefficient (for a review of these concepts Sharan et al., 2007).
At low correlation thresholds, we found that both the set of 755 genes (“755 net-
work”) and randomly resampled sets of genes (“random networks”) formed networks
characterised by a single, large connected component. This expected structure starts to
break down into multiple connected components at |ρ| > 0.50 in the 755–network, and
at |ρ| > 0.35 in random networks, with the former having consistently higher number of
connected genes (Figure 1A). The number of connected components was also on average
higher in the 755 network than in the random networks, but only at |ρ| = 0.85 was this
greater than for all random networks. The largest number of connected components for
both the 755– and random networks was observed at a threshold of |ρ| = 0.75, after which
some of these structures become completely unconnected and disappear (Figure 1B).
The median number of genes in connected components showed little difference between
the 755–network and random ones (Figure 1C), but the size of the largest connected
component in the 755 network was consistently above that observed for random net-
works (Figure 1D) across a wide threshold range. The average number of connections
of genes in any component (their degree) of the 755–network was consistently higher
than for random networks (Figure 1E), suggesting tighter overall correlation. The ex-
tent of connectivity within the component to which a gene belongs (measured by the
clustering coefficient) was also higher for the 755 network at 0.55 ≤ |ρ| ≤ 0.75; however,
this measure becomes erratic above 0.775 due to the reduced size of the network at these
stringent thresholds (Figure 1F).
In summary, the observed 755–network generated consistently higher number of cor-
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relations across a range of thresholds, generated a higher average level of connectivity
between genes and a greater level of inter–connectivity between the neighbours of a
given gene, than was observable in random networks of the same size derived from all
expressed genes, suggesting that these genes are indeed responding to the influences of
regulatory variation. We settled on a threshold of |ρ| = 0.775, which gave us maximal
differences between the 755–network and background without dissolving structure due
to high stringency.
The cross tissue correlation network
We constructed a |ρ| = 0.775 correlation network containing 212 (28.1%) genes that
correlate with at least one other transcript; the genes have a median degree of 4, with
73% of genes with a degree of ≥ 2 (Figure 2). These genes are central to our subsequent
study; in principle they are influenced by genetic variation(s) that influence mRNA levels
in all three tissues simply because the correlation statistic is calculated across all three
tissues. Performing similar analyses on subsets of tissues, we find that at the same
threshold a further 204 (27.0%) genes are correlated in any pair of tissues, and a further
191 (25.3%) are correlated in any single tissue. A total of 607 (80.4%) of the 755 genes
exhibit correlated behaviour in any network, suggesting that shared regulatory influences
upon gene expression are widespread, and over 55% are correlated in multiple tissues
(data not presented).
In the original network across all tissues, we find that the 212 genes fall into 19
discrete correlating groups of genes or CGGs; of these groups, 10 contain at least three
members and the largest 5 contain 75, 63, 21, 12 and 6 genes respectively; all 19 CGGs
are displayed in Figure 2 along with their expression patterns across the 31 BXD lines
and the 3 tissues.
Given that CGGs are constructed from combinations of pair–wise relationships be-
tween genes, we expected that the levels of each transcript within a CGG (grey lines in
Figure 2) should in general be similar. To assess the extent to which variation in a sin-
gle genes mRNA could be explained by the shared influences upon a CGG, we correlated
(using the coefficient of determination, R2, see Methods) the expression pattern of each
transcript to the centroid of their respective CGG (thick coloured lines in Figure 2)
for each tissue individually, and across all 3 tissues simultaneously; we determined the
statistical significance of the observed R2 via permutation (see Methods). R2 values
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ranged from ∼ 0.4 to ∼ 0.9 (Figure 3) and in most cases there was very limited overlap
with randomly sampled genes. The permutation analysis shows that the behaviour of
the genes in the CGG cannot easily be explained by inter-array differences in hybridi-
sation; in this case we would expect the random permutations also to generate higher
R2 values. We note that even though CGG 1 in the brain has the smallest R2 values,
which overlap with randomly sampled genes, this CGG nevertheless exhibits significantly
unusual biological behaviour that independently supports the notion it is a CGG (see
below). We conclude from this analysis that shared behaviour is a significant influence
upon genes within CGGs and that the shared influence upon genes in CGG (∼40–90%
from Figure 3) is comparable in magnitude to the size of effects reported for cis–acting
eQTLs Hubner et al. (2005); Petretto et al. (2006); Stranger et al. (2005); West et al.
(2007).
While we have illustrated the congruous behaviour of mRNAs within a CGG, we also
note from Figure 2 that mRNA level profiles between each tissue are strikingly different.
This is supported by calculating the correlation between the intra–tissue centroids for
each CGG (Table 1): the only statistically significant relationship is in fact an anti–
correlation between the centroids of CGG 2 in Brain and Liver (ρ = −0.59, P = 5.94×
10−4). These results show that whilst genes within a CGG are highly correlated to each
other, consistent with the idea of being influenced by shared factors, the outcome of
such regulation is markedly different in each tissue, such that the overall pattern of a
group’s expression in each tissue is at best, uncorrelated, or even anti-correlated. These
differences are best explained by genetic variation in multiple regulatory components
that act individually in a tissue specific fashion or in a single cross tissue component
whose behaviour is itself modulated by tissue specific factors.
The collective behaviour of CGGs
We have identified CGGs based on their expression patterns across a panel of BXD mice,
and across three tissues. Within each individual BXD animal, all genes in a CGG should
be coordinately regulated, even if this differs across tissues. If these levels are indeed
due to genetic differences in the regulatory factors controlling ultimate mRNA level,
then we would expect that CGG members should display similar correlated expression
patterns across different genetic backgrounds. However, the multiple, complex changes in
genetic background implicit in this experiment are unlikely to result in exactly the same
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mRNA levels in any two individuals; therefore, rather than test for identical expression
of all genes in the CGG, we designed a test for the identical direction of mRNA levels:
relatively up– or down–regulated. This co-ordinated expression over all genes in a CGG
can be summarised as a coherency score: the proportion of genes whose mRNA levels
are up–regulated relative to the reference (see Figure 4a for an example, and Methods
for details).
We performed simulation studies to assess the performance of the coherency score
with respect to both the number of genes in a CGG, and the magnitude and variability
of the expression changes (see Supplementary Material). Simulating the conditions
of our experiment, we identified that the score is adequately powered to detect coherent
directionality of expression for CGGs of at least 10 genes (at permuted P < 0.05). Below
this group size, the score had little power even in the case of maximal coherency.
We applied this method to the 4 largest CGGs (those having between 75 and 12
genes). Given the CGG had been defined solely by analysis of the BXD RI strains,
we therefore looked at coherency in the two progenitor strains, C57BL/6J and DBA/2J
and found that all 4 CGGs were significantly coherent (P = 0.001) in at least one
tissue (Figure 4b and Supplementary Table 1). We note that CGG 1 in the brain,
which had the lowest R2 values to its centroid, nevertheless exhibits high coherency
(coherency=0.76, P = 0.001); whilst the shared contribution to overall mRNA levels of
the CGG might be relatively small, there is a marked effect upon direction of mRNA level
changes. We also note that the 63 genes in CGG 2 have complex properties: coherency
is moderate in size, but still significant in Brain (coherency −0.52; P = 0.001) and
Kidney (coherency −0.46; P = 0.001) and not coherent in Liver (coherency −0.08;
P = 0.33). However, close inspection (Figure 2) reveals that this CGG comprises two
sub domains, one highly interconnected domain (CGG2A) containing 38 genes, which
are loosely connected to a less interconnected group of 25 genes (CGG2B). These two
sub-domains exhibit more coherent expression: CGG2A in Brain −0.63 (P = 0.001),
Kidney −0.79 (P = 0.001) and Liver −0.74 (P = 0.001) and CGG2B in Brain −0.36
(P = 0.013), in Kidney 0.04 (P = 0.15) and Liver 0.92 (P = 0.001). This illustrates the
complexity of the correlations within the network where the existence of CGGs defined
by correlation alone does not capture the full relationships of mRNA levels.
To validate these observations, we performed an independent comparison of a distinct
inbred mouse strain, SJL/J to C57BL/6J (see Methods). Given the close genetic
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relationship between DBA/2J and SJL/J (Beck et al., 2000), we expected that these
4 CGGs should (A) be coherent in each tissue, and (B) show similar directionality as
DBA/2J with respect to C57BL/6J. We found both predictions to be true, with all
CGGs being coherent in at least one tissue (P < 0.05; see Figure4b, row 2, and
Supplementary Table 2), and most CGGs that were coherent in both DBA/2J and
SJL/J having the same directionality in the same tissue (those entries with ** for both
strains in Figure 4c). These findings confirm that these groups of genes are indeed
collectively sensitive to genetic influence, even in this more distant inbred strain.
Inter–strain and inter–individual coherency
These observations provide independent biological confirmation of the properties of
CGGs, and also reveal the complex outcomes of genetic influence upon mRNA levels.
In these 3 inbred strains, mRNA levels of the same groups of genes co–ordinately vary
not just between strains but also between the same tissues between each strain. If this
behaviour is indeed genetic in origin, as we have argued, then we would also expect the
same to be true in the BXD lines. We therefore calculated coherency for the four largest
CGGs in the three tissues of each BXD line relative to C57L/6J and compared this to
the coherency of DBA/2J expression. Due to the small number of replicate microarrays
used for each measure (6 for DBA/2J, 3 for SJL/J and 1 for each BXD RI), we limit
our inferences of differential regulation to extreme cases, where a high score in DBA/2J
becomes of high magnitude but opposite sign in at least one BXD strain. We note that
a simple Mendelian effect would result in either a coherency score approximating +/−1
for a DBA/2J allele or 0 for a C57BL/6J allele, which is the reference strain. We use
permutation to assign significance to these events, assessing the likelihood that a given
coherency would occur by chance in our dataset (see Methods).
We find CGG 2 in kidney changes from −0.46 in DBA/2J to +1.00 in 2 BXD lines;
CGG3 in brain changes from +0.33 to −1.00 in 3 BXD lines, in kidney from +1.00 to
−1.00 in an BXD line, in liver from −1.00 to +1.00 in 7 BXD lines; CGG 4 in brain
from +0.83 to −1.00 in 4 BXD lines, in kidney from −0.83 to +1.00 in 6 BXD lines. The
pattern of changes in coherency of CGG 3 in kidney shown in Figure 5A is compatible
with segregation of variations within the BXD lines and the consistent up–regulation of
mRNA levels in the kidney for most of the BXD lines for CGG 4 (Figure 5B) is sup-
portive of transgressive segregation of genetic influences. (see Supplementary Table 3
11
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
08
.1
79
9.
1 
: P
os
te
d 
14
 A
pr
 2
00
8
for full coherency scores from the BXD panel, DBA/2J and SJL/2J). Collectively, these
results suggest that genetic variation has influences that result in the effective tissue
specificity of changes in mRNA levels and that even the direction of this change is not
readily predictable either within or between individuals.
This analysis identifies dramatic changes in coherency of CGGs across the panel,
supporting the genetic origin of this phenomenon, and allows us to define some extreme
coherency alterations that are likely segregating within the BXD lines. However, we
acknowledge the lack of power to draw more specific conclusions as to the full range of
coherency phenotypes displayed across the complete strain collection.
Encoded protein functions and CGG identity
The existence of CGGs could be interpreted, at the extremes, as either the inevitable
outcome of shared and partially shared mRNA level control or of a more specific regula-
tory architecture evolved to have functional outcomes. To address this latter possibility,
we sought to find functional relationships within CGGs, whose sizes allow for statisti-
cally valid analyses, using Gene Ontology (GO) Biological Process terms (Ashburner
et al., 2000). We found convincing evidence of functional clustering in CGG 2 and
CGG 4. In CGG 4, ten of the fourteen transcripts are annotated: six are ribosomal
proteins (Rps29, Rps15, Rplp2, Rplp1, Rpl35A and Rpl19 ), and two are ribosomal pro-
tein/ubiquitin fusions (Fau and Uba52 ), and showed a highly significant enrichment for
translation (GO:0006412; P = 2 × 10−6). CGG 2 contains 63 genes, 35 with GO an-
notations: 13 are involved in carbohydrate metabolism, 5 involved in signalling and 4
involved in transport and was enriched for carbohydrate metabolic process (GO:0005975;
P = 2.1× 10−4). We note that CGG 2 illustrates the complexity of breaking a network
into discrete sub–networks: whilst we can analyse CGG 2 as a whole, there remains
distinct functional clustering even within the CGG. These findings are compatible with
some CGGs having functional significance but certainly do not support the view that
shared function is the major determinant of CGG gene content.
We have stressed that the genetic influences upon CGGs do not have to be at the
level of the control of transcription but this is nevertheless a plausible hypothesis that is
testable. To study this, we examined the CGGs for over-representation of transcription
factor (TF) binding sites (TFBs); our reasoning is that transcriptional control of a CGG
could be due to shared action of TFs and that a variant TF could then contribute
12
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to the differential mRNA levels across our BXD panel. Our results are summarised
in Supplementary Table 4 and here we discuss only CGG 2; we identified 24 TFs,
including FOXD3, TCF1, EN1, SP1, GFI1, NKX2–5, IRF2, and 17 TFs of the Sox
family (Sox1 to Sox9, Sox11 to Sox13 and Sox15, Sox17, Sox18, Sox21 and Sox30 )
whose cognate binding sites were present in more of the promoters of the 63 genes in
CGG 2 than expected by chance (P < 0.05) (see Methods) suggesting they may be
involved in the regulation of the genes. If any of the TFs are contributing to variation
in CGG 2 mRNA levels, we may be able to detect genetic association of the TF gene
with the mRNA levels of some or all of the genes in CGG 2. To identify association, we
carried out an eQTL analysis across all 3 tissues to test for linkage of any of the 63 genes
in CGG 2 to the closest genetic marker to each of the 24 TF genes identified above (see
Methods).
The marker D8Mit124 located ∼2.3Mb distal of the Sox1 gene on chromosome 8 had
median P−values of 0.001 for the 63 mRNA levels in the brain compared to 0.410 for all
other gene/TF marker combinations, 0.012 in the kidney compared to 0.422 and 0.015
in the liver compared to 0.488. Whilst the individual P−values do not reach significance
under a Bonferroni correction there is nevertheless a striking incidence of low P−values
to this marker. This result is compatible with the hypothesis that some of the variation
in CGG 2 mRNA levels, in all three tissues, may be caused by genetic variation in the
Sox1 gene or protein: the gene is located in a region of low polymorphism and there are
no immediate candidate coding or non-coding SNPs. Proving involvement of Sox1 will
require an experimental design that is outside the scope of this study.
Discussion
In this study we have taken advantage of different genetic backgrounds, to identify
groups of genes whose mRNA levels are likely to be under shared genetic influences
across multiple tissues. We have focused on examining the inbred strains C57BL/6J
and DBA/2J and limited our analyses of genetic influence only to those genes that
were expressed over a defined mRNA level in brain, kidney and liver and that were
differentially expressed between the parental strains in one or more of these tissues:
we identify 755 genes subject to such genetic influence. Using pairwise comparisons of
mRNA levels across 31 recombinant inbred lines of mice derived from this pair of parental
strains, we detect “correlating groups of genes” or CGGs, whose mRNA levels change
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co–ordinately across all 31 strain in all three tissues. We then studied the same genes
in the unrelated strain SJL/J and showed that they also exhibit CGG- like behaviour
and exhibit co–ordinately up– or down–regulated levels of mRNA, as appropriate. We
further show a striking feature of some CGGs is that genetic variation influences the same
genes in divergent fashions in different tissues of the same individual; genes in a CGG
may be relatively up–regulated in one (or more) tissue(s) but relatively down–regulated
in another. Unpredictable behaviour is also seen in the behaviour of CGGs compared
across different individuals: for example, mRNAs of a CGG may be up–regulated in the
brain of one strain but down–regulated in the brain of a second and we have observed
this in replicated studies of C57BL/6J, DBA/2J and SJL/J, as well as in individual BXD
strains. This unpredictability is quite unlike the effects of a protein sequence variation
where an amino acid change is the same in every tissue that expresses the relevant exon.
We identify genetic influence in these studies by detecting pairs of genes whose mRNA
levels vary co–ordinately in our analyses; however, the proportion of the 755 genes
that are affected is entirely determined by the cut–off used to construct the correlation
network. Consistent with previous analyses (Freeman et al., 2007), we have shown that
there is no simple single criterion that we can use to define this cut–off (indeed there is
no plausible biological reason why there should be a discrete value) but using the cut–
offs employed for the three tissue analyses, we can show that 80% of the 755 genes are
genetically influenced in one or more tissues, suggesting these complex genetic influences
are common. It is also likely there are groups of co–regulated genes that would not have
been included in our initial 755– gene analysis but that are revealed as being genetically
influenced due to their being subject to transgressive segregation in the BXD lines.
The apparently common but unpredictable influence of genetic variation prompted us
to develop the use of coherency testing, essentially testing the direction rather than
amount of relative mRNA levels change, for analysis of relative CGG gene behaviour.
We believe this is a robust and appropriate test of a CGG that is not based upon the
extreme view that mRNA levels should be identical between 2 genetically dissimilar
individuals. Further extensions to the present methods of coherency testing are also
possible; our current approach is limited to testing the extent to which groups of genes
show uniform changes in expression, but if more complex patterns of co–regulation could
be specified, these approaches could remain informative.
Our data adds to three lines of evidence suggesting that the influence of genetic
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variation is frequently tissue specific. Firstly, several microarray based surveys have
highlighted differences in gene expression across different brain regions in inbred mouse
strains (Freeman et al., 2007; Hovatta et al., 2007; Nadler et al., 2006; Pavlidis and
Noble, 2001; Sandberg et al., 2000) and these differences in expression appear to be
phenotypically relevant, as shown by analysis of inter–strain differences in motor coor-
dination tasks (Nadler et al., 2006). Secondly, analyses of eQTL data from studies in
different tissues have shown limited evidence for tissue specific effects Bystrykh et al.
(2005); Chesler et al. (2005); Gatti et al. (2007); Hubner et al. (2005). Thirdly, Yang
et al. (2006), using an inter–cross of C57BL/6J and C3H/HeJ mouse strains, and sam-
pling muscle, liver, adipose and brain, demonstrated the essentially tissue specific nature
of expression of sexually dimorphic, but not more general, classes of genes.
Functional annotation of genes within each CGG showed that in some cases genes
whose mRNA levels were highly correlated also encode proteins with biologically related
functions; the clearest examples are 13 proteins involved in sugar metabolism clustered
in CGG2 and 6 ribosomal proteins in CGG4. The correlated behaviour of functionally
related genes is perhaps not surprising in view of numerous studies on the co–regulation
of gene expression; our major conclusion however is that shared function does not appear
to be the primary organising principle of most genes within a CGG. In this respect, a
better understanding of the shared behaviour of the CGG and its relationship if any, to
phenotypic outcomes (Goring et al., 2007; Nadler et al., 2006; Passador-Gurgel et al.,
2007), will provide greater insight into the functional consequences of CGG variation
and shared control.
The proportion of the variation in an individual genes mRNA level that can be
ascribed to shared CGG influences ranges from 40-90%, which is very similar to reported
results of eQTL analyses, in particular of effects which are in cis to a gene (Hubner et al.,
2005; Petretto et al., 2006; Stranger et al., 2005; West et al., 2007). Logically, influences
shared between 2 or more genes are difficult to reconcile with cis acting variations and
the smaller effects on mRNA levels of the trans acting influences detectable in eQTL
studies suggests that the correlation influences we detect are the outcome of numerous,
additive, in trans influences that are individually not easy to detect. We note that our
study design is, like most other published accounts, underpowered to detect significant
eQTLs at a whole genome scale and we have therefore not attempted this approach at
a global level. We do however provide evidence that multi-factorial trans–acting genetic
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variants must exist; appearing to influence gene groups of modest size, as supported by
previously published eQTL analyses.
Steady–state mRNA levels are set by a complex set of regulatory interactions, only
some of which will be primary modulations of transcription. Our findings for CGG 2
that the Sox binding site is over-represented and mRNA levels of the genes within the
CGG exhibit unusual linkage at the region harbouring Sox1, suggest an involvement of
this transcription factor in CGG 2 behaviour but this is necessarily speculative. The
reality is that our methods, in common with all such analyses, including eQTL based
approaches, cannot distinguish between primary and secondary influences upon mRNA
levels. For example, whether an unobserved common regulator causes CGG 2 behaviour,
or variation in more distal processes, such as signal transduction, will have to be shown
by extensive mechanistic dissection, but such follow–up studies will minimally have to
be able to distinguish between these alternatives.
In more general terms, we have focused upon correlation–based approaches in our
study with the assumption that correlation is a likely outcome of biological processes
rather than simply using correlation as a statistical tool. This study has not been de-
signed to identify, in most cases, the cause of a change in mRNA level but rather we
have simply focused upon defining, at the level of mRNA, the phenotypic differences
between two organisms that are likely due to the sum total of all relevant genetic in-
fluences. Of course, changes in mRNA levels do not have to be reflected in changing
protein levels and in most cases it is this latter change that will contribute to phenotypic
diversity. Recent studies in yeast from Foss et al. (2007) have shown there is only weak
correlation of mRNA and protein levels tested across genetically divergent strains, and
so prediction from purely genotypic information of ultimate protein levels, and therefore
potential phenotype, is going to be a very challenging task even at a single tissue, let
alone at a multiple tissue or organismal level. Nevertheless, the observation that this
type of genetic variation has strong tissue specific outcomes suggests that the regulatory
architecture of mRNA levels may have evolved, in part, to generate selective phenotypic
diversity of individual tissues and could represent a contributing source of morphological
and functional evolutionary differences.
Finally, if tissue specificity of genetic influence is replicated in humans, then using
mRNA levels measured in readily available surrogate tissues will not easily predict out-
comes in more relevant tissues and this will have very substantial implications for the
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design of human studies.
Methods
RNA preparation
Eight week old, male Mus musculus strains C57BL/6J, DBA/2J and SJL/J were ob-
tained from the Biological Resources Centre, UNSW (Sydney, Australia) and Mus mus-
culus BXD/TyJ strains 1, 2, 5, 6, 8, 9, 11–16, 18–24, 27–29, 30–34, 36, 38, 39, 40, and
42 were obtained from the Jackson Laboratories (Bar Harbor, ME, USA). Whole brain,
kidney and liver tissues were harvested according to protocols approved by the University
of New South Wales Animal Care and Ethics Committee (Ethics Code ACEC 01/43),
and snap frozen in liquid N2. Total RNA was extracted according to the manufacturer’s
instructions with TRIzol Reagent (Invitrogen, Mt. Waverley, Vic, Australia); purity and
integrity was assessed by OD260/OD280 readings greater than 2 and intact rRNA bands
(Agilent Bioanalyzer, Agilent, Forest Hills, Vic, Australia) analysis, respectively.
Parental strain experiment: Total RNA from the three tissues of 10 individuals
was pooled for each strain (9 for liver) to remove individual variation in gene expression;
20 µg of pooled RNA and 2 µg of Lucidea Universal Scorecard Spike–in (Amersham Bio-
sciences, Castle Hill, NSW, Australia) were reverse transcribed using the SuperScript III
Indirect cDNA Labelling System (Invitrogen, Mt. Waverley, Vic, Australia) and fluo-
rescently labelled with Alexa Fluor 555 for C57BL/6J and Alexa Fluor 647 for DBA/2J
(Invitrogen, Mt. Waverley, Vic, Australia).
BXD panel experiments: Equal amounts of total RNA from 3 animals from each
BXD strain were mixed to give tissue pools representative of the genetic backgrounds. A
common reference sample was created for each tissue from total RNA extracted from ten
eight–week–old male C57BL/6J mice (a different RNA source than the parental strain
experiment). 20 µg of pooled RNA was reverse transcribed (as above) and fluorescently
labelled with Alexa Fluor 555 for C57BL/6J and Alexa Fluor 647 for BXD strain samples
(as above).
C57 versus SJL experiment: Total RNA from the brain, kidney and liver of
five C57BL/6J and five SJL/J individuals was pooled for each strain. cDNA synthesis
was same as for C57BL/6J vs. DBA/2J experiment, but sodium tetraborate instead
of sodium bicarbonate was used in the labelling buffer. Again, C57BL/6J cDNA was
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labelled with Alexa Fluor 555 and SJL/J with Alexa Fluor 647 for DBA/2J (Invitrogen,
Mt. Waverley, Vic, Australia).
Microarray experiments
Parental experiment: For each tissue, labelled cDNA was directly compared on 6
replicate glass slide two-colour microarrays containing the Compugen Mouse OligoLi-
brary representing 21,997 genes and Lucidea Universal ScoreCard (Clive and Vera Ra-
maciotti Centre for Gene Function Analysis, UNSW, Sydney, Australia), in 100 µL of
DIGEasy buffer (Roche, Basel, Switzerland) with 5 µL each yeast tRNA and calf thymus
DNA as blockers (Invitrogen, Mt. Waverley, Vic, Australia). Utility controls from the
Lucidea Scorecard were not used, and therefore served as additional negative controls.
Hybridised microarrays were washed in 1 × SSC, three times in 1 × SSC, 0.1% SDS at
50◦C, and three times in 1×SSC, dried by centrifugation, and scanned with the GenePix
4000B microarray scanner (Axon Instruments, Union City, CA, USA). BXD panel ex-
periments: Identical arrays and processing as above, with one array being performed
for each tissue in each BXD line, giving a total of 31× 3 = 93 arrays. C57 versus SJL
experiment: Identical arrays and processing as above, but three microarrays per tissue
were performed per tissue, giving a total of 3× 3 = 9 arrays.
Data processing
Image analysis was performed with the Spot image analysis software version 2 (CSIRO,
Australia, texttthttp://experimental.act.cmis.csiro.au/Spot/index.php). All further data
processing and statistical analyses were performed using R version 2.0.0 (Ihaka and Gen-
tleman, 1996). Gene expression data were morph background corrected and log2 trans-
formed. Data for controls and the 232 replicated spots of the housekeeping gene Gapd
(NM 008084) were removed prior to normalization to avoid bias. Parental experi-
ment: All 18 slides were then normalized for intensity and spatial bias using print–tip
loess and then quantile adjusted to adjust for the differing scale of measurements across
arrays (Yang et al., 2001), and replicate slides were averaged. BXD panel experi-
ments: All 93 slides were normalized using print–tip loess. To standardise across ex-
periments from the three tissues, we sub–selected the data from genes considered to be
expressed in all 3 tissues in the parental experiment and then applied quantile normaliza-
tion. The log2 ratios of intensities, M = log2R− log2G, (referred to as M−values) were
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subsequently used as expression measurements. C57BL/2J vs. SJL/J experiment:
Processing as for parental experiment.
Differential expression in parental strains across multiple tissues
We classified genes as reliably detected if their log mean intensity, A = 0.5(log2R+ log2G),
was greater than the 95–th percentile of negative controls present on our arrays, in all
three tissues. B statistics were then calculated for all genes, using default parameters in
the R limma library version 1.8.6 (Smyth, 2004), part of the Bioconductor project (Gen-
tleman et al., 2004); genes were classified as genetically influenced if they had both a
B−statistic (LOD)> 3 and an A−value greater than the intensity threshold. 6,075 genes
were detected above in all three tissues; and of these 755 were genetically influenced in
one or more tissue.
Cross-tissue correlation analysis
In order to identify the genes that have similar expression patterns to gene gi in all
tissues, we adopted a correlation-based approach. There are 3 per–tissue expression
matrices, Ebrain, Ekidney and Eliver, each of dimension G×S, where G is the number of
genes and S is the number of strains, that is, 755 genes×31 strains in the present case.
Pairs of genes that are correlated with each other in all three tissues are of primary
interest because they may be under the influence of some common, tissue independent
regulatory mechanisms. We identify such pairs of genes by joining the three per-tissue
expression matrices Ebrain, Ekidney and Eliver into a single G×3S cross–tissue expression
data matrix:
EBKL = (Ebrain|Ekidney|Eliver)
We then computed a G×G correlation matrix, CBKL, from EBKL using Spearman’s ρ
as a distance measure. CBKL is referred to as the cross–tissue correlation matrix. CBKL
was then hard thresholded for various values of |ρ|, thus defining the adjacency matrix,
C∗BKL, representing an undirected simple graph. In the present study, all networks
were generated using a threshold of |ρ| ≥ 0.775 (see next section for discussion). The
cross-tissue co–expression network, defined from this adjacency matrix, was visualised
using custom R code using the igraph and RGL libraries. Nodes in Figure 2 were laid
out using the 2D–Fruchterman–Reingold algorithm (Fruchterman and Rheingold, 1991),
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computed using implementations available in the igraph library in R, and visualised
using the rglplot function (see figure legends for specific details).
CGG centroid R2 analysis
The centroid of each CGG is the per–strain average M–value for all genes in the CGG,
which we calculated for each tissue independently, or from all three tissues combined. To
determine the similarity of each gene in the CGG to its centroid, we compute R2 as the
square of the Pearsons product–moment coefficient (r), obtaining a distribution of R2
values for all genes in the CGG. We assess the statistical significance of the observed R2,
by permutation analysis. We repeat this analysis for random CGGs, chosen by randomly
sampling the same number of genes from the set of 755 genes, obtaining a distribution of
R2 values for each gene in the random CGG, to the random CGGs centroid. We compare
the observed distribution of R2 to the random distribution using the Mann–Whitney U
test, using the upper–tail P−values. We repeat this for 1000 random CGGs, and count
the number of times the P−value < 0.05, divided by the number of permutations.
Similar results are obtained if the random genes are resampled from the set of 6075
genes, or if the random genes are compared to the observed CGGs centroid, rather than
the random CGGs centroid (data not presented).
Inter–BXD–strain coherency
The coherency test-statistic is designed to measure how consistent the directionality of
relative expression is in a set of genes (see Results: The collective behaviour of
CGGs). Given the expression ratios (M−values) from the comparison of two strains
(such as C57BL/6J vs. DBA/2J), and a set of genes, G = {g1, . . . , gN}, with corre-
sponding measurements of average relative expression, Mˆg, across a set of replicates,
associated with each gene, the vertex–based coherency, CG is calculated as follows:
CG =
∑N
k=1 sign(Mˆgk)
N
where sign is the sign function, defined as:
sign(x) =

1 if x > 0
0 if x = 0
−1 if x < 0
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Thus, this vertex-based-coherency score ranges from [−1, 1], with values closer to
+1 indicating more coherent up-regulated expression, values closer to −1 indicating
more coherent down-regulated expression and values closer to 0 indicating less coherent
expression. Permutation test: we chose 1000 random sets of G genes, from a set of 755
genes (by permuting gene labels) and assessed the significance of the observed coherency
of each CGG using the following formula:
P =
#{|CG∗ | ≥ |CG|}
B
where G∗ denotes a randomised version of gene set G, defined using the label-permuted
set of 755 genes, and B is the number of such permutations generated. For example,
if the given CGG had a vertex–based–coherency score of 0.77 and of 1000 randomised
samples, only 6 scores were observed to be larger than 0.77, then the P−value would be
6/1000=0.006
To test for the significance of a coherency score in just a single microarray test on
a single BXD strain, we resample the appropriate number of genes in a CGG from
the 755 gene set, conditional on the observed coherence of the actual CGG genes in
DBA/2J–vs–C57 experiment; for example if coherence of 10 genes is +0.8 we randomly
identify 8 up regulated and 2 down regulated in the DBA/2J–vs–C57 comparison and
calculate the coherence of these genes in each of the 31 BXD lines, repeating the process
1000 times. We score and individual BXDs coherency score as being significant only if
observed coherencies equal or greater than all 1000 random tests (or less than for −ve
coherency).
Gene Ontology analysis
To test for enrichment or depletion of a GO term in a set of genes of interest, we
tested whether genes of interest were mapped to the GO term at a level greater than
chance expectation (defined as the observable proportion of genes mapping to the term
in the set of expressed genes in the experiment) using sampling without replacement
from the hypergeometric distribution (using the phyper function in R). We used a strict
Bonferroni correction for P < 0.05, corrected for the number of terms with > 5 genes
annotated to them, either directly or via transitive relationships in the ontology. We
employed the Bioconductor package GO (v1.1.14), and mapped microarray identifiers
(GenBank ids) to Entrez Gene ids based on probe-sequence-similarity using custom
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scripts (available on request).
Transcription factor binding motifs
The GenBank sequences for each of the 6,075 expressed genes were aligned to the ncbi35.1
build of the mouse genome using BLAT (version 32x1; Kuhn et al., 2007), and the best
hits were retained. The upstream 1000 bp from these sequences was then retrieved using
BioPerl into FastA formatted files. Repeat regions were masked to lowercase letters
using RepeatMasker (version open–3.1.6) and RepBase (version 20061006) using the
following flags: “--species mouse --xsmall --gff”. Then the upstream sequences
for all of the genes in each connected component were separated into a separate FastA
formatted file. The Transcription Factor motif library from JASPAR (Vlieghe et al.,
2006) was downloaded (jaspar2005core) and formatted to suit CLOVER using tools from
the clover download page (http://zlab.bu.edu/clover) (Frith et al., 2004). CLOVER:
Cis–eLement OVERrepresentation (version Mar 29 2006) was run to search for over-
represented motifs in the upstream sequences from the genes in each regulon compared
to a background set of sequences from the 6075 expressed genes. This data was permuted
1000 times to generate P−values for over/under representation in the data sets. The
following flags were used when running clover: “-l -t 0.05”.
eQTL analysis for genes in CGG2
For all expression phenotypes in CGG2 (63 genes), we calculated linkage test statistics for
the closest marker (www.webqtl.org; Chesler et al., 2004) to each of the 24 transcription–
factor encoding genes whose binding motifs were enriched in the proximal promoters of
genes in CGG2. We identified the SOX binding motif as being over-represented, and since
most SOX proteins are expected to recognised the same motif (P Koopman, personal
communication), we consider all Sox genes. This analysis was performed in each of the
three tissues separately. We estimated significance of linkage to each marker using likeli-
hood ratio statistics (LRS) and model–based P−values calculated using the QTL Reaper
code (v1.1.0 with single marker analysis option; www.genenetwork.org/qtlreaper.html).
We corrected the number of comparisons (marker × gene × tissue) using the Bonferroni
correction.
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Figure Legends
Figure 1: Network properties of the 755 genes across a range of correlation
thresholds. Networks were constructed for a range of correlation thresholds from 0.05
to 1.0, and each resulting network was tested for: (A) the number of gene–gene correla-
tions (edges) in the network; (B) the number of connected components in the network;
(C) the median connected component size (log scale on y−axis); (D) the size (number of
genes) of the largest connected component (log scale on y−axis); (E) the average degree
of all vertices (log scale on y−axis); and (F) the clustering co–efficient. Within each plot,
the solid black dots are the observed data points in the cross-tissue correlation network,
with the 0.775 data point displayed as an open circle. 1000 network permutations were
performed (see text) to generate a null distribution, which is represented as the grey
area. The heavy dashed line is the mean of the null distribution.
Figure 2: (A): Correlations between genes are displayed as a graph: edges connect two
genes if those genes are correlated with an absolute value of Spearmans |ρ| > 0.775. 212
of the 755 genetically influenced genes (see text) pass this threshold and are positioned
in the x − y plane based on a 2–dimensional Fruchterman-Reingold layout algorithm
(Fruchterman and Reingold, 1991). Disconnected clusters of genes (CGGs) with at least
three genes in them are coloured and numbered. (B) panels show expression differences
of genes in the relevant CGGs measured in each BXD strain in 3 tissues (1st panel brain,
2nd kidney and 3rd liver). The vertical axis is fold change vs. C57BL/6J (M−values)
of mRNA level in each of the 31 BXD strains (horizontal axis). Each individual genes
M−values are plotted as grey lines, with thick coloured lines representing the CGG cen-
troids (blue, green and red for brain, kidney and liver respectively). Note the striking
differences of the same genes expression patterns in the three different tissues.
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Figure 3: CGGs are highly correlated to their own centroid. In each plot, the centroid
for the CGG was computed, and the distributions of R2 of each gene in the CGG to the
centroid is plotted as a thick coloured line, with R2 along the x−axis, and the density
along the y−axis. The grey lines in each plot correspond to the distributions of R2 from
1000 randomly sampled sets of genes (see Methods). Row 1 contains data generated
from combining the gene expression data from the three single-tissues together, and rows
2–4 correspond to using the single-tissue gene expression data from brain, kidney and
liver respectively. Columns 1–5 correspond to CGGs 1–5, respectively.
Figure 4: Coherency analysis. (A) Coherency overview: a CGG containing 12 genes
is identified by correlation analysis in the 31 BXD strains; the expression ratios from a
comparison of the progenitor mouse strains for each of these 12 genes are shown (most
genes are up–regulated); the coherency score is calculated (see supplementary informa-
tion); statistical significance is determined via permutation; the resulting coherency, and
statistical significance are displayed as an annotated histogram. This process is repeated
for all CGGs, in expression data from all three tissues, and for two separate pair–wise
comparisons of strains (see below). (B) Coherency results: we plot the coherency scores
for each CGG, in the brain, kidney and liver for the comparison of DBA/2J vs C57BL/6J
in the first row (blue, green and red, respectively), and for SJL/J vs C57BL/6J in the
second row (light blue, light green and orange, respectively). Stars indicate the degree
of statistical significance (∗ = P < 0.05, ∗∗ = P < 0.005). (C): The same data as in (B),
but re–ordered so that the tissues are grouped together.
Figure 5: changes in coherency across the individual BXD strains. The coherency
of CGG3 in Kidney (A) and CGG4 in Kidney (B) in all 33 strains investigated in this
study. The CGG depicted in (A) has the whole range of variable expression patterns,
from completely up–regulated, to completely down–regulated. All genes in the CGG
depicted in (B) are down–regulated in DBA/2J, but in the majority of BXD strains (all
of which contain differing amounts of the DBA/2J genetic background), all genes in the
same CGG are up–regulated.
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